Graciela Rodríguez-Sevilla

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 85 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Global Emergence of Resistance to Fluconazole and Voriconazole in <i>Candida parapsilosis</i> in Tertiary Hospitals in Spain During the <scp>C</scp>OVID-19 Pandemic

Nuria Trevijano‐Contador, Alba Torres-Cano, Cristina Carballo-González et al. · Open Forum Infectious Diseases · 2022 · 50 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Evaluation of a commercial multiplex PCR (Unyvero i60 ® ) designed for the diagnosis of bone and joint infections using prosthetic-joint sonication

Laura Prieto-Borja, Graciela Rodríguez-Sevilla, Álvaro Auñón et al. · Enfermedades Infecciosas y Microbiología Clínica · 2016 · 34 citations

Medicine, Infectious Diseases, Orthopaedic Surgery +15

Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model

Graciela Rodríguez-Sevilla, Marta García-Coca, David Romera-García et al. · International Journal of Medical Microbiology · 2018 · 33 citations

Life Sciences, Infectious Diseases, Microbiology +16

Angiotensin II and Adrenocorticotropin Release: Mediation by Endogenous Corticotropin-Releasing Factor^*

Eduardo Spinedi, Graciela Rodríguez-Sevilla · Endocrinology · 1986 · 30 citations

Medicine, Endocrinology, Pharmacology +15